Rodriguez, Rachelle D.
Anderson, Ashley E. L.
Gwathmey, Kelly G.
Brethenoux, Caroline R.
Shea, Lisa M.
Govindarajan, Raghav
Souayah, Nizar
Peters, Wesley D.
Jackson, Louis A.
Choudhry, Zia U.
Article History
Received: 8 August 2025
Accepted: 6 October 2025
First Online: 22 October 2025
Declarations
:
: Rachelle D. Rodriguez was an employee of Johnson & Johnson at the time of the study, and is currently consulting for Gilead Sciences through Biopoint and Star Epidemiology. Ashley E. L. Anderson has served on the speaker’s bureau for Alexion Pharmaceuticals and has served on advisory boards and as a paid consultant for Johnson & Johnson. Kelly G. Gwathmey reports consulting for Argenx, UCB, and Alexion, and speaking engagements for Alexion. Caroline R. Brethenoux is an employee of Human Dot Plus, a research company paid by Johnson & Johnson to undertake the analyses for this study. Lisa M. Shea is an employee of Johnson & Johnson, and owns stock or stock options in Johnson & Johnson. Raghav Govindarajan has served on advisory boards for Argenx, UCB, Janssen, Roche, and speakers’ bureaus for Argenx, Alexion, and UCB. Nizar Souayah reports having no conflicts to disclose. Wesley D. Peters is an employee of Evidera, which derives profits from interactions with pharmaceutical sponsors. Louis A. Jackson is an employee of Johnson & Johnson and owns stock or stock options in Johnson & Johnson. Zia U. Choudhry is an employee of Johnson & Johnson, and owns stock or stock options in Johnson & Johnson.
: A post hoc/secondary qualitative analysis from transcripts of participants in focus groups were used for this study. Participants in the focus group were informed that participation was voluntary, that responses would be recorded, that no treatments would be provided, and that they could withdraw at any time. Participants signed a consent and release form that communicated confidentiality and Health Insurance Portability and Accountability Act (1996)-compliant practices. Data were anonymized. The original research was classified as market research, and therefore institutional review board approval was not needed. The focus group and analysis were conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.For the digital conversation analysis, topic-specific data were collected from public domain sources only. These data were collected in an unidentified manner, and analysis was conducted on aggregated data only. No personal information, identifiers, or other identification-related information were collected. Data were stored on secure servers only while analysis was conducted and then purged per General Data Protection Regulation privacy guidelines. The study was therefore exempt from the need for institutional review board review.